The point-of-care testing (POCT) market would grow at a CAGR of 10.92% over the predicted time frame. The market is expected to increase in value from US$ 45.03 Bn in 2022 to US$ 103.2 Bn in 2030.
Key Takeaways:
- North America was accounted highest revenue share more than 46% in 2021.
- Asia Pacific POCT market is registering at a CAGR of 9.8% from 2022 to 2030.
- By product, glucose monitoring products segment has captured highest revenue share 27% in 2021.
- By platform, lateral flow assays segment has accounted 36% revenue share in 2021.
- By mode of purchase, OTC testing products segment has held 59% revenue share in 2021.
- The glucose monitoring segment was valued at USD 8.91 billion in in 2021.
- The biosensors segment is growing a CAGR of 9.2% during the frorecast period.
- The pregnancy and fertility testing products segment is expected to reach at a 8.1% of CAGR from 2022 to 2030.
- The diagnostic centers segment is growing at a CAGR of 7.8% over the forecast period.
The on point-of-care testing (POCT) Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/2270
A recent report provides crucial insights along with application based and forecast information in the Global Point-of-care testing (POCT) Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Point-of-care testing (POCT) market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Point-of-care testing (POCT) market are included as given below:
Point-of-care testing (POCT) Market Key Players are: Sinocare Inc, Hoffmann La Roche Ltd, Siemens AG, Abott Laboratories, bioMrieux SA, Becton Dickinson and Company, Danaher Coraporation, Nova Biomedical, Sysmex corporation, Johnson and Johnson, Biosensor Inc, Fluxergy, Precision, Ascensia Diabetes Care Holding AG, LifeScan IP Holdings, LLC, Mankind pharma, OraSure Technologies, inc, A. Menarini Diagnostics s.r.l, ACON Laboratories, Trinity Biotech plc
Market Segments
By Product Type
- Covid -19 testing kits
- Glucose monitoring products
- Meters
- Strips
- Lancets and Lancing devices
- Cardiometabolic Monitoring Products
- Cardiac maker testing products
- Blood Gas / Electrolyte testing products
- HbA1c testing products
- Infectious disease testing products
- Influenza testing products
- HIV testing products
- Hepatitis testing products
- Sexually Transmitted Diseases testing products
- Healthcare - associated Infection testing products
- Respiratory infection testing products
- Tropical disease testing products
- others
- Coagulation monitoring products
- PT / INR testing
- ACT / APTT
- Pregnancy and fertility testing products
- Pregnancy testing products
- Fertility testing products
- Cancer marker testing products
- Urinanalysis testing products
- Cholestrol testing products
- Hematology testing products
- Drugs-of-abuse testing products
- Fecal Occult testing products
- Others
By Platform
- Lateral Flow Assays
- Dipsticks
- Microfluids
- Molecular Diagnostics
- Immunoassays
By Mode of Purchase
- OTC products
- Prescribed based products
By Testing Type
- Immunoassays
- Cell-Based Assays
- Nucleic Acid Amplification Testing
- Clinical Chemistry Assays
- Hematology
By End-User
- Clinical laboratories
- Ambulatory care facilities and physician offices
- Pharmacies, retail clinics & E-comm platforms
- Hospitals, Critical care centres, Urgent care centres
- Home care & self-testing
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Report Objectives
- To define, describe, and forecast the global point-of-care testing (POCT) market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the point-of-care testing (POCT) market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Point-of-Care Testing (POCT) Market
5.1. COVID-19 Landscape: Point-of-Care Testing (POCT) Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Point-of-Care Testing (POCT) Market, By Product Type
8.1. Point-of-Care Testing (POCT) Market, by Product Type, 2022-2030
8.1.1. Covid -19 testing kits
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Glucose monitoring products
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Cardiometabolic Monitoring Products
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Infectious disease testing products
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Coagulation monitoring products
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Pregnancy and fertility testing products
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Pregnancy testing products
8.1.7.1. Market Revenue and Forecast (2017-2030)
8.1.8. Fertility testing products
8.1.8.1. Market Revenue and Forecast (2017-2030)
8.1.9. Cancer marker testing products
8.1.9.1. Market Revenue and Forecast (2017-2030)
8.1.10. Urinanalysis testing products
8.1.10.1. Market Revenue and Forecast (2017-2030)
8.1.11. Cholestrol testing products
8.1.11.1. Market Revenue and Forecast (2017-2030)
8.1.12. Hematology testing products
8.1.12.1. Market Revenue and Forecast (2017-2030)
8.1.13. Drugs-of-abuse testing products
8.1.13.1. Market Revenue and Forecast (2017-2030)
8.1.14. Fecal Occult testing products
8.1.14.1. Market Revenue and Forecast (2017-2030)
8.1.15. Others
8.1.15.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Point-of-Care Testing (POCT) Market, By Platform
9.1. Point-of-Care Testing (POCT) Market, by Platform, 2022-2030
9.1.1. Lateral Flow Assays
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Dipsticks
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Microfluids
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Molecular Diagnostics
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Immunoassays
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Point-of-Care Testing (POCT) Market, By Mode of Purchase
10.1. Point-of-Care Testing (POCT) Market, by Mode of Purchase, 2022-2030
10.1.1. OTC products
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Prescribed based products
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Point-of-Care Testing (POCT) Market, By Testing Type
11.1. Point-of-Care Testing (POCT) Market, by Testing Type, 2022-2030
11.1.1. Immunoassays
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Cell-Based Assays
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Nucleic Acid Amplification Testing
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Clinical Chemistry Assays
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Hematology
11.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Point-of-Care Testing (POCT) Market, By End-User
12.1. Point-of-Care Testing (POCT) Market, by End-User, 2022-2030
12.1.1. Clinical laboratories
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Ambulatory care facilities and physician offices
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Pharmacies, retail clinics & E-comm platforms
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Hospitals, Critical care centres, Urgent care centres
12.1.4.1. Market Revenue and Forecast (2017-2030)
12.1.5. Home care & self-testing
12.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Point-of-Care Testing (POCT) Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.1.2. Market Revenue and Forecast, by Platform (2017-2030)
13.1.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.1.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.1.5. Market Revenue and Forecast, by End-User (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Platform (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.1.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.1.6.5. Market Revenue and Forecast, by End-User (2017-2030)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.1.7.2. Market Revenue and Forecast, by Platform (2017-2030)
13.1.7.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.1.7.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.1.7.5. Market Revenue and Forecast, by End-User (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.2.2. Market Revenue and Forecast, by Platform (2017-2030)
13.2.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.2.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.2.5. Market Revenue and Forecast, by End-User (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Platform (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.2.7. Market Revenue and Forecast, by Testing Type (2017-2030)
13.2.8. Market Revenue and Forecast, by End-User (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Platform (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.2.10. Market Revenue and Forecast, by Testing Type (2017-2030)
13.2.11. Market Revenue and Forecast, by End-User (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Platform (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.2.12.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.2.13. Market Revenue and Forecast, by End-User (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Platform (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.2.14.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.2.15. Market Revenue and Forecast, by End-User (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.3.2. Market Revenue and Forecast, by Platform (2017-2030)
13.3.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.3.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.3.5. Market Revenue and Forecast, by End-User (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Platform (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.3.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.3.7. Market Revenue and Forecast, by End-User (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Platform (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.3.9. Market Revenue and Forecast, by End-User (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Platform (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.3.10.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.3.10.5. Market Revenue and Forecast, by End-User (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Platform (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.3.11.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.3.11.5. Market Revenue and Forecast, by End-User (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.4.2. Market Revenue and Forecast, by Platform (2017-2030)
13.4.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.4.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.4.5. Market Revenue and Forecast, by End-User (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Platform (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.4.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.4.7. Market Revenue and Forecast, by End-User (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Platform (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.4.9. Market Revenue and Forecast, by End-User (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Platform (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.4.10.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.4.10.5. Market Revenue and Forecast, by End-User (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Platform (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.4.11.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.4.11.5. Market Revenue and Forecast, by End-User (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.5.2. Market Revenue and Forecast, by Platform (2017-2030)
13.5.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.5.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.5.5. Market Revenue and Forecast, by End-User (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Platform (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.5.6.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.5.7. Market Revenue and Forecast, by End-User (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product Type (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Platform (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Mode of Purchase (2017-2030)
13.5.8.4. Market Revenue and Forecast, by Testing Type (2017-2030)
13.5.8.5. Market Revenue and Forecast, by End-User (2017-2030)
Chapter 14. Company Profiles
14.1. Sinocare Inc
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Hoffmann La Roche Ltd
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Siemens AG
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Abott Laboratories
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. bioMrieux SA
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Becton Dickinson and Company
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Danaher Coraporation
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Nova Biomedical
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9.Sysmex corporation
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Johnson and Johnson
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments